Clinical Trial Update: Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ADCV01 as add-on therapy for primary glioblastoma (GBM) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• ADCV01

Snippet

Sponsor: Ever Supreme Bio Technology Co., Ltd. | Conditions: GBM | Phase 2 | Status: RECRUITING